Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Phenylpiperazine

From Wikipedia, the free encyclopedia
(Redirected from1-phenylpiperazine)
Not to be confused withSubstituted phenylpiperazine.
Phenylpiperazine
Skeletal formula of phenylpiperazine
Ball-and-stick model of the phenylpiperazine molecule
Names
Preferred IUPAC name
1-Phenylpiperazine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard100.001.969Edit this at Wikidata
UNII
  • InChI=1S/C10H14N2/c1-2-4-10(5-3-1)12-8-6-11-7-9-12/h1-5,11H,6-9H2 checkY
    Key: YZTJYBJCZXZGCT-UHFFFAOYSA-N checkY
  • c1cc(ccc1)N2CCNCC2
Properties
C10H14N2
Molar mass162.23 g/mol
Appearanceclear colourless to yellow liquid
Density1.028g/cm3
Melting point18.8 °C (65.8 °F; 291.9 K)
Boiling point287.2 °C (549.0 °F; 560.3 K) at 760mmHg
insoluble
Hazards
Flash point138.3 °C (280.9 °F; 411.4 K)
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
Chemical compound

1-Phenylpiperazine (1-PP orPP) is a simplechemical compound anddrug featuring aphenylgroup bound to apiperazinering.[1] The suffix ‘-piprazole’ is sometimes used in the names ofdrugs to indicate they belong to this class.[2]

It is a rigidanalogue ofamphetamine.[1][3][4] Similarly to amphetamine, 1-PP is amonoamine releasing agent, withEC50Tooltip half-maximal effective concentration values formonoamine release of 186 nM fornorepinephrine, 880 nM forserotonin, and 2,530 nM fordopamine.[1] Based on the preceding values, it is about 4.7-fold lesspotent in releasing serotonin than norepinephrine and about 13.6-fold less potent in releasing dopamine than norepinephrine.[1] Hence, 1-PP is a modestlyselectivenorepinephrine releasing agent (NRA), or could alternatively be thought of as an imbalancedserotonin–norepinephrine releasing agent (SNRA) orserotonin–norepinephrine–dopamine releasing agent (SNDRA).[1]

Other homologues and rigid analogues of amphetamine besides 1-PP include2-aminotetralin (2-AT),2-amino-1,2-dihydronaphthalene (2-ADN),2-aminoindane (2-AI),1-naphthylaminopropane (1-NAP),2-naphthylaminopropane (2-NAP),6-ABTooltip 6-amino-6,7,8,9-tetrahydro-5H-benzocycloheptene, and7-ABTooltip 7-amino-6,7,8,9-tetrahydro-5H-benzocycloheptene.[3][4][5]

1-Phenylpiperazine showstoxicity at sufficiently high doses; itsoralLD50 in rats is 210 mg/kg.[6]

Numerousderivatives of 1-PP, orsubstituted phenylpiperazines, exist.[7][1] Some examples includemeta-chlorophenylpiperazine (mCPP),3-trifluoromethylphenylpiperazine (TFMPP), andpara-methoxyphenylpiperazine (pMeOPP).[7][1][8]

See also

[edit]

References

[edit]
  1. ^abcdefgSeverinsen K, Kraft JF, Koldsø H, Vinberg KA, Rothman RB, Partilla JS, Wiborg O, Blough B, Schiøtt B, Sinning S (September 2012)."Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters".ACS Chem Neurosci.3 (9):693–705.doi:10.1021/cn300040f.PMC 3447394.PMID 23019496.
  2. ^World Health Organization (WHO) (2006)."The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances"(PDF). Archived fromthe original(PDF) on 2008-12-14. Retrieved27 April 2010.
  3. ^abOberlender R, Nichols DE (March 1991)."Structural variation and (+)-amphetamine-like discriminative stimulus properties".Pharmacology, Biochemistry, and Behavior.38 (3):581–586.doi:10.1016/0091-3057(91)90017-V.PMID 2068194.S2CID 19069907.
  4. ^abGlennon RA, Young R, Hauck AE, McKenney JD (December 1984). "Structure-activity studies on amphetamine analogs using drug discrimination methodology".Pharmacol Biochem Behav.21 (6):895–901.doi:10.1016/s0091-3057(84)80071-4.PMID 6522418.
  5. ^Hathaway BA, Nichols DE, Nichols MB, Yim GK (May 1982). "A new, potent, conformationally restricted analogue of amphetamine: 2-amino-1,2-dihydronaphthalene".Journal of Medicinal Chemistry.25 (5):535–538.doi:10.1021/jm00347a011.PMID 6123601.
  6. ^"1-Phenylpiperazine".pubchem.ncbi.nlm.nih.gov.
  7. ^abElliott S (2011). "Current awareness of piperazines: pharmacology and toxicology".Drug Test Anal.3 (7–8):430–438.doi:10.1002/dta.307.PMID 21744514.
  8. ^Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB (October 2004). "Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain".Ann N Y Acad Sci.1025:189–197.doi:10.1196/annals.1316.024.PMID 15542717.

External links

[edit]
DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
Phenylpiperazines
Benzylpiperazines
Naphthylpiperazines
Quinolinylpiperazines
Diphenylalkylpiperazines
Pyrimidinylpiperazines
Pyridinylpiperazines
Benzo(iso)thiazolylpiperazines
Tricyclic-linked piperazines
Others/uncategorized
Stimulants
Depressants
Hallucinogens
Entactogens
Psychiatric drugs
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=Phenylpiperazine&oldid=1283107164"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp